18F
-FDG
|
Fluorodeoxyglucose F18
|
AD
|
Alzheimer’s disease |
ALS |
Amyotrophic lateral sclerosis |
ALS-FRS-R |
ALS functional rating scale revised |
ASO |
Antisense oligonucleotide |
Bi |
Behavioral impairment |
Bci |
Behavioral and cognitive impairment |
BMI |
Body mass index |
C9orf72 |
Chromosome 9 open reading frame 72 |
Ci |
Cognitive impairment |
CEP |
CarboxyEthylPyrole |
CHIT1 |
Chitotriosidase 1 |
CNS |
Central nervous system |
CSA |
Cross-sectional areas |
CRP |
C-reactive protein |
CSF |
Cerebrospinal fluid |
DPRs |
Dipeptide repeats |
EEG |
Electroencephalography |
EVs |
Extracellular vesicles |
fALS |
Familial ALS |
FoxP3 |
Forkhead box P3 |
FUS |
Fused in sarcoma |
FTD |
Frontotemporal dementia |
FVC |
Force vital capacity |
HDL |
High density lipoprotein |
IL-6 |
Interleukin-6 |
LMN |
Lower motor neurons |
MND |
Motor neuron disease |
MMP1 |
Matrix metalloproteinase 1 |
MRI |
Magnetic Resonance Imaging |
MRN |
Magnet resonance neurography |
MUAP |
Motor unit action potential |
MUNIX |
Motor unit number index |
MUNE |
Motor unit number estimation |
NCT |
Nuclear cytoplasmic transport |
MPO |
Myeloperoxidase |
Nf |
Neurofilaments |
PBMC |
Peripheral blood mononuclear cells |
PET |
Positron emission tomography |
PFC |
Prefrontal cortex |
PLS |
Primary lateral sclerosis |
PMA |
Progressive muscular atrophy |
PNS |
Peripheral nervous system |
REE |
Resting energy expenditure |
ROI |
Region of interest |
sALS |
Sporadic ALS |
SOD1 |
Superoxide dismutase 1 |
TDP-43 |
TAR DNA-binding protein 43 |
TARDBP |
TAR DNA-binding protein |
UMN |
Upper motor neurons |